[AVTE] YoY Quarter Result on 31-Mar-2024 [#Q1]

Stock
[AVTE] Aerovate Therapeutics, Inc.
Announcement Date
13-May-2024
Financial Year
2024
Quarter
31-Mar-2024 [#Q1]
Profit Trend
QoQ- -13.58%
YoY- -50.55%
Quarter Report
AVTE's Result
AVTE's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 CAGR
Revenue 0 0 0 0 0 -
PBT -23,186 -16,520 -10,910 -2,781 -1,436 100.36%
Tax 0 -1,119 -109 -1 38 -
NP -23,186 -15,401 -10,801 -2,781 -1,436 100.36%
Tax Rate - - - - - -
Total Cost 23,186 15,401 10,801 2,781 1,436 100.36%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 CAGR
EPS -0.83 -0.62 -0.44 -0.13 -0.32 26.88%
EPS Diluted -0.83 -0.62 -0.44 -0.13 -0.32 26.88%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.